ResearcherSecond Military Medical UniversityActive in the last 2 years
Yuxin Shen
Matched on ORCID iD 0009-0004-1742-0797; OpenAlex author ID A5101311753. Sources: OpenAlex.
Their work
- Papers
- 11 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 10
2016: 1 paper · 2017: 1 paper · 2018: 4 papers · 2019: 1 paper · 2020: 1 paper · 2021: 2 papers · 2022: none · 2023: none · 2024: 1 paper
Papers 11
- Dietary inflammatory potential and pancreatic cancer risk: a systematic review and dose-response meta-analysis First author DOI 10.21203/rs.3.rs-4761786/v1↗
- Personalized designs of adjuvant radiotherapy for pancreatic cancer based on molecular profiles. Co-author DOI 10.1111/cas.14486↗
- Re-Irradiation With Stereotactic Body Radiotherapy for In-Field Recurrence of Pancreatic Cancer After Prior Stereotactic Body Radiotherapy: Analysis of 24 Cons… Co-author DOI 10.3389/fonc.2021.729490↗
- Validation of the eighth edition of the AJCC staging system for patients with pancreatic adenocarcinoma initially receiving chemoradiotherapy and proposal of m… Co-author DOI 10.20892/j.issn.2095-3941.2019.0101↗
- Patterns of Local Failure After Stereotactic Body Radiation Therapy and Sequential Chemotherapy as Initial Treatment for Pancreatic Cancer: Implications of Tar… Co-author DOI 10.1016/j.ijrobp.2019.01.075↗
- Prospective analysis of different combined regimens of stereotactic body radiation therapy and chemotherapy for locally advanced pancreatic cancer. Co-author DOI 10.1002/cam4.1553↗
- Prediction of overall survival after re-irradiation with stereotactic body radiation therapy for pancreatic cancer with a novel prognostic model (the SCAD scor… Co-author DOI 10.1016/j.radonc.2018.08.012↗
- Stereotactic body radiation therapy plus induction or adjuvant chemotherapy for early stage but medically inoperable pancreatic cancer: A propensity score-matc… Co-author DOI 10.2147/cmar.s163655↗
- Health-related quality of life for gemcitabine and nab-paclitaxel plus radiotherapy versus gemcitabine and S-1 plus radiotherapy in patients with metastatic pa… Co-author DOI 10.2147/cmar.s166713↗
- Prognostic role of stereotactic body radiation therapy for elderly patients with advanced and medically inoperable pancreatic cancer. Co-author DOI 10.1002/cam4.1164↗
- Safety and efficacy of stereotactic body radiation therapy combined with S-1 simultaneously followed by sequential S-1 as an initial treatment for locally adva… Co-author DOI 10.1136/bmjopen-2016-013220↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yangsen Cao · 10 shared papers, 2016–2021 · strength 0.88
- Paper Personalized designs of adjuvant radiotherapy for pancreatic cancer based on molecular profiles. DOI 10.1111/cas.14486↗
- Paper Re-Irradiation With Stereotactic Body Radiotherapy for In-Field Recurrence of Pancreatic Cancer After Prior Stereotacti… DOI 10.3389/fonc.2021.729490↗
- Paper Validation of the eighth edition of the AJCC staging system for patients with pancreatic adenocarcinoma initially recei… DOI 10.20892/j.issn.2095-3941.2019.0101↗
- Shuiwang Qing · 10 shared papers, 2016–2021 · strength 0.88
- Paper Personalized designs of adjuvant radiotherapy for pancreatic cancer based on molecular profiles. DOI 10.1111/cas.14486↗
- Paper Re-Irradiation With Stereotactic Body Radiotherapy for In-Field Recurrence of Pancreatic Cancer After Prior Stereotacti… DOI 10.3389/fonc.2021.729490↗
- Paper Validation of the eighth edition of the AJCC staging system for patients with pancreatic adenocarcinoma initially recei… DOI 10.20892/j.issn.2095-3941.2019.0101↗
- Xiaofei Zhu · 10 shared papers, 2016–2021 · strength 0.88
- Paper Personalized designs of adjuvant radiotherapy for pancreatic cancer based on molecular profiles. DOI 10.1111/cas.14486↗
- Paper Re-Irradiation With Stereotactic Body Radiotherapy for In-Field Recurrence of Pancreatic Cancer After Prior Stereotacti… DOI 10.3389/fonc.2021.729490↗
- Paper Validation of the eighth edition of the AJCC staging system for patients with pancreatic adenocarcinoma initially recei… DOI 10.20892/j.issn.2095-3941.2019.0101↗
- Huojun Zhang · 10 shared papers, 2016–2021 · strength 0.88
- Paper Personalized designs of adjuvant radiotherapy for pancreatic cancer based on molecular profiles. DOI 10.1111/cas.14486↗
- Paper Re-Irradiation With Stereotactic Body Radiotherapy for In-Field Recurrence of Pancreatic Cancer After Prior Stereotacti… DOI 10.3389/fonc.2021.729490↗
- Paper Validation of the eighth edition of the AJCC staging system for patients with pancreatic adenocarcinoma initially recei… DOI 10.20892/j.issn.2095-3941.2019.0101↗
- Mingxia Chen · 1 shared paper, 2024 · strength 0.28
- Jiang Li · 1 shared paper, 2024 · strength 0.28
- Yusheng Ye · 1 shared paper, 2021 · strength 0.13
- Lingong Jiang · 1 shared paper, 2021 · strength 0.13
- Di Chen · 1 shared paper, 2020 · strength 0.11
- Wenyu Liu · 1 shared paper, 2018 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.